BioPharm Systems Launches New Tool for Transferring Oracle Clinical Data
BioPharm Systems announced that it has launched a new solution which enables life sciences companies that use Oracle Clinical, Oracle's clinical data management system, to copy studies between Oracle Clinical environments.
The Oracle Clinical Study Copy Tool is a flexible application that can be used for tasks such as transferring clinical studies from one Oracle Clinical instance to another, archiving a global library or clinical studies, and refreshing patient data in a non-production environment.
"We originally developed this Oracle Clinical application for a company that needed to migrate their global library and clinical studies from an external Oracle Clinical instance to a BioPharm Systems hosted environment," said Michelle Engler, principal consultant, BioPharm Systems. "During the development of the solution, several other companies showed interest in its broad capabilities, so we decided to release it to the greater clinical trials community."
Pharmaceutical, biotechnology, and medical device companies, in addition to clinical research organizations and academic institutions who license the solution can choose to either employ it on their own or have BioPharm Systems service their specific needs. Although it has zero footprint in Oracle Clinical, the application's security is maintained via Oracle Clinical and its standard credential controls.
Improving Relationships and Diversifying the Site Selection Process
April 17th 2025In this episode of the Applied Clinical Trials Podcast, Liz Beatty, co-founder and chief strategy officer, Inato, discusses a number of topics around site engagement including community-based sites, the role of technology in improving site/sponsor relationships, how increased operational costs are impacting the industry, and more.
Behind the Buzz: Why Clinical Research Leaders Flock to SCOPE Summit
February 7th 2025In this episode, we meet with Micah Lieberman, Executive Conference Director for SCOPE Summit (Summit for Clinical Ops Executives) at Cambridge Innovation Institute. We will dive deep into the critical role of collaboration within the clinical research ecosystem. How do we bring together diverse stakeholders—sponsors, CROs, clinical trial tech innovators, suppliers, patients, sites, advocacy organizations, investors, and non-profits—to share best practices in trial design, program planning, innovation, and clinical operations? We’ll explore why it’s vital for thought leaders to step beyond their own organizations and learn from others, exchanging ideas that drive advancements in clinical research. Additionally, we’ll discuss the pivotal role of scientific conferences like SCOPE Summit in fostering these essential connections and collaborations, helping shape the future of clinical trials. Join us as we uncover how collective wisdom and cross-industry partnerships are transforming the landscape of clinical research.
FDA-Approved Gene Therapy Beqvez Shows Sustained Efficacy, Safety in Long-Term Hemophilia B Trial
April 17th 2025Beqvez (fidanacogene elaparvovec), an FDA-approved one-time gene therapy for hemophilia B, demonstrated sustained factor IX expression, low bleeding rates, and a favorable safety profile over long-term follow-up.
